Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-72.83	7.26	26.73
Graham Fair Price	75.76	50.06	28.48
PEG	-94.26	0.01	-0.24
Price/Book	-1.44	1.12	1.14
Price/Cash Flow	11.66	7.63	6.84
Prices/Earnings	-63.13	3.32	9.00
Price/Sales	-17.38	3.58	4.33
Price/FCF	11.66	7.63	6.84
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	141.66	0.36	0.15
ROA	184.91	0.01	< 0.005
ROE	0.03	0.08	167.35
ROIC	0.01	0.04	179.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.05	-80.84
Dividends QOQ	< 0.005	-0.03	208.00
EBIT QOQ	-0.35	2.17	514.50
EPS QOQ	-0.37	2.37	542.69
FCF QOQ	-0.07	-0.03	55.20
Revenue QOQ	0.05	0.31	487.89
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.53	0.51	-3.97
Quick Ratio	4.24	5.23	23.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.75	36.28	7.49
Cash	43.84	54.67	24.70
Capex	0.00	0.00	0.00
Free Cash Flow	5.63	5.34	-5.12
Revenue	8.88	11.39	28.23
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.24	5.23	23.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.62	-2.13	-18.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating